Obesity and chronic obstructive pulmonary disease: Is fatter really better?

Canadian Respiratory Journal

Volumn 21, Issue 5, 2014, Pages 297-301

  Galesanu, Roxana G ^a   Bernard, Sarah ^a   Marquis, Karine ^a   Lacasse, Yves ^a   Poirier, Paul ^a   Bourbeau, Jean ^b   Maltais, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

COPD; Muscle; Obesity; Survival

Indexed keywords

AGED; ANTHROPOMETRY; ARTERIAL GAS; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; LIPID STORAGE; LONGITUDINAL STUDY; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDTHIGH MUSCLE CROSS SECTIONAL AREA; MUSCLE ATROPHY; MUSCLE MASS; OBESITY; OXYGEN SATURATION; PROSPECTIVE STUDY; SURVIVAL; WORK CAPACITY; BLOOD GAS ANALYSIS; CANADA; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; RADIOGRAPHY; SKELETAL MUSCLE; THIGH;

AGED; ANTHROPOMETRY; BLOOD GAS ANALYSIS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUEBEC; RESPIRATORY FUNCTION TESTS; THIGH;

EID: 84908556524     PISSN: 11982241     EISSN: 19167245     Source Type: Journal    
DOI: 10.1155/2014/181074     Document Type: Article

References (36)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
2. Marquis K, Debigaré R, LeBlanc P, et al. Mid-thigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with COPD. Am J Respir Crit Care Med 2002;166:809-13.
3. Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia MA, Sanchez PR, Salcedo E, Navarro M. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest 2005;128:2108-15.
4. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
5. Poulain M, Doucet M, Drapeau V, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis 2008;5:35-41.
6. Sava F, Laviolette L, Bernard S, Breton M, Bourbeau J, Maltais F. The impact of obesity and overweight on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med 2010;10:55.
7. Franssen FM, O'Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax 2008;63:1110-7.
8. van den Bemt L, van Wayenburg CA, Smeele IJ, Schermer TR. Obesity in patients with COPD, an undervalued problem? Thorax 2009;64:640; author reply 640-1.
9. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763-78.
10. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-96.
11. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: The obesity paradox. Am J Cardiol 2003;91:891-4.
12. Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55-61.
13. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-54.
14. Lavie CJ, Mehra MR, Milani RV. Obesity and heart failure prognosis: Paradox or reverse epidemiology? Eur Heart J 2005;26:5-7.
15. Jordan JG Jr, Mann JR. Obesity and mortality in persons with obstructive lung disease using data from the NHANES III. South Med J 2010;103:323-30.
16. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
17. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-7.
18. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: Findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.
19. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis 2008;5:205-209.
20. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: Role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167:544-9.
21. Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE. Combined effects of obesity and COPD on dyspnea and exercise tolerance. Am J Respir Crit Care Med 2009 15;180:964-71.
22. National Institutes of Health, National Heart Laboratory. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1998;(6 Suppl 2):51S-209S.
23. Bernard S, Leblanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
24. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-S120.
25. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J 1993;(Suppl 16):5-40.
26. Belsey DA, Kuh K, Welsch RE. Regression diagnostics: Identifying Influential Data and Sources of Collinearity. New York: John Wiley & Sons, 1980.
27. Kotler DP. Cachexia. Ann Intern Med 2000;133:622-34.
28. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62:115-20.
29. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793-801.
30. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med 2002;162:1477-81.
31. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:591-7.
32. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the torch study. Am J Respir Crit Care Med 2008;178:332-8.
33. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887.
34. Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-9.
35. Furutate R, Ishii T, Wakabayashi R, et al. Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011;6:423-30.
36. van den Borst B, Gosker HR, Koster A, et al. Body Composition S. The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease. Am J Clin Nutr 2012;96:516-26.